[1]Clurman B E,Roberts J M. Cell cycle and cancer[J]. Journal of the National Cancer Institute,1995,87(20):1 499-1 501.
[2] Hwang H C,Clurman B E. Cyclin E in normal and neoplastic cell cycles[J]. Oncogene,2005,24(17):2 776-2 786.
[3] Loeb K R,Kostner H,Firpo E,et al. A mouse model for cyclin E-dependent genetic instability and tumorigenesis[J]. Cancer Cell,2005,8(1):35-47.
[4] Sotiriou C,Wirapati P,Loi S,et al. Gene expression profiling in breast cancer:understanding the molecular basis of histologic grade to improve prognosis[J]. Journal of the National Cancer Institute,2006,98(4):262-272.
[5] Wykoff C C,Beasley N J P,Watson P H,et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases[ J].Cancer Research,2000,60(24):7 075-7 083.
[6] Meiron M,Anunu R,Scheinman E J,et al. New isoforms of VEGF are translated from alternative initiation CUG codons located in its 5忆UTR[J]. Biochemical and Biophysical Research Communications,2001,282(4):1 053-1 060.
[7] 陈彬,李琥,穆超,等. 大鼠正畸牙移动中HIF-1α的表达[J]. 口腔生物医学,2011,2(2):78-81.
[8] H?ckel M,Schlenger K,H?ckel S,et al. Hypoxic cervical cancers with low apoptotic index are highly aggressive[J]. Cancer Research,1999,59(18):4 525-4 528.
[9] Rademakers S E,Span P N,Kaanders J H A M,et al. Molecular aspects of tumour hypoxia[ J]. Molecular Oncology,2008,2(1):41-53.
[10] Fanale D,Bazan V,Corsini L R,et al. HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions[J]. Breast Cancer Research and Treatment,2013,140(3):505-517.
[11] Tan P,Cady B,Wanner M,et al. The cell cycle inhibitor p27 is an independent prognostic marker in small(T1a,b) invasive breast carcinomas[J]. Cancer Research,1997,57(7):1 259-1 263.
[12] Bartek J,Lukas J. Pathways governing G1/ S transition and their response to DNA damage[J]. FEBS Letters,2001,490(3):117-122.